ArticleFrontiers in oncology2026

The prognostic value of peripheral blood inflammatory markers in patients with HER2-positive metastatic breast cancer treated with pyrotinib.

Wenqi Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.